X-Rx announces FDA acceptance of IND for X-165, a potential treatment for Idiopathic Pulmonary Fibrosis
US-based biotech company X-Rx has received a major boost in its quest to develop new treatments for Idiopathic Pulmonary Fibrosis (IPF) with the US Food ... Read More
Tamr partners with Accenture to tackle data challenges in drug discovery
Tamr Inc. has officially joined Accenture’s open partner ecosystem, a strategic collaboration designed to enhance efforts in drug discovery and patient outcomes. This initiative aims ... Read More
Clovis Oncology secures EC approval for Rubraca’s new indication in ovarian cancer treatment
In a major win for Clovis Oncology, the European Commission (EC) has granted approval for an expanded indication for its cancer drug, Rubraca (rucaparib). This ... Read More
Eusa Pharma completes $115m acquisition of Sylvant for iMCD treatment
Eusa Pharma has successfully acquired the global rights to Sylvant (siltuximab), a drug used in the treatment of idiopathic multicentric Castleman’s disease (iMCD), from Janssen ... Read More
Takeda’s $62bn acquisition of Shire: A game-changing move for global pharma
In a landmark deal, Takeda Pharmaceutical Company has successfully completed its previously announced acquisition of Shire, an Irish biotech leader specializing in rare diseases, for ... Read More
Parsvottanasana Pyramid Pose
How to do Parsvottanasana Pyramid Pose? Watch this video to do Parsvottanasana Pyramid Pose. window.__ventunoplayer = window.__ventunoplayer||[];window.__ventunoplayer.push({video_key: 'MTIxMjA3MHx8NTc4fHwxNTd8fDEsMiwx', holder_id: 'vt-video-player', player_type: 'vp', width:'100%', ratio:'16:9'}); Read More
How to make Telangana Chicken recipe
Check out how to prepare Telangana Chicken Telangana Chicken Ingredients Chicken - 350 gms Oil - 2 Tbsp Curry Leaves Onion - 2 Nos Thinly ... Read More
Lilly to acquire Loxo Oncology in $8bn deal: A game-changer in precision cancer treatment
Eli Lilly and Company (Lilly), a global leader in pharmaceuticals, has made headlines with its announcement to acquire Loxo Oncology, a pioneering biopharmaceutical company based ... Read More
Bristol-Myers Squibb to acquire Celgene in $74bn pharma megadeal
Bristol-Myers Squibb has reached a definitive agreement to acquire Celgene Corporation in a monumental cash-and-stock deal worth approximately $74 billion. This acquisition will merge two ... Read More
InventisBio licenses lung cancer drug D-0316 to Betta Pharma in RMB230m deal
In a significant development within the pharmaceutical industry, Shanghai-based InventisBio has entered into a strategic partnership with Betta Pharmaceuticals Co., Ltd. to co-develop the promising ... Read More